Results from the PPKM2Tg mice showed that PKM2 activation would preserve VEGF, eNOS, and angpt1 expression even with diabetes, and this correlated with the retained eGFR in people protected from CKD with very long duration (>50 years) of T1D. This evidence concerns the gene PKM and chronic kidney disease.